ArticleMolecular biology reports2026
Tunicamycin-induced endoplasmic reticulum stress triggers ZBP1-Mediated PANoptosis in macrophages and mouse spleen.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoplasmic reticulum stress (ERS) plays a pivotal role in regulating immune cell fate. While ERS is known to induce apoptosis, its contribution to the recently defined inflammatory cell death pathway, PANoptosis, remains unclear. This study aimed to elucidate how tunicamycin-induced ERS regulates Z-DNA binding protein 1 (ZBP1)-mediated PANoptosis in macrophages and mouse spleen.
methodsRAW264.7 macrophages were treated with tunicamycin to induce ERS. Cell viability, proliferation, migration, and invasion were assessed by CCK-8, colony formation, wound-healing, and Transwell assays. ERS-related and PANoptosis-associated molecules were analyzed by RT-qPCR and Western blotting. Reactive oxygen species (ROS) generation, apoptosis, and cytokine secretion were quantified by flow cytometry and ELISA. The ER stress inhibitor 4-phenylbutyric acid (4-PBA) and RNA sequencing were used to explore regulatory mechanisms. An in vivo tunicamycin mouse model was established to validate ERS-induced PANoptosis in spleen tissue.
resultsTunicamycin significantly suppressed macrophage proliferation, migration, and invasion by activating the GRP78/PERK/eIF2α/ATF4/CHOP pathway and increasing ROS levels. ERS upregulated ZBP1 and RIPK3 expression, accompanied by activation of apoptotic (Caspase-3/7/8), necroptotic MLKL (mixed lineage kinase domain-like protein)/p-MLKL, and pyroptotic GSDMD (gasdermin D)/GSDME (gasdermin E) markers, and increased secretion of IL-6, TNF-α, IL-1β, and IL-18, indicating PANoptosis induction. 4-PBA alleviated ERS, reduced ZBP1 and CHOP expression, and restored cell viability. RNA-seq analysis confirmed enrichment of ERS and inflammatory death pathways. In vivo, tunicamycin triggered ZBP1 upregulation and PANoptotic features in mouse spleen.
conclusionThese findings demonstrate that tunicamycin-induced ERS activates the GRP78/PERK/eIF2α/ATF4/CHOP pathway and provides the first evidence that ER stress alone can trigger ZBP1-mediated PANoptosis in macrophages and mouse spleen, highlighting the ER stress–ZBP1–PANoptosis axis as a novel mechanism linking ERS to inflammation and immune dysregulation.
Indexed as
Identifiers
42029716What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.